Publications de Fabienne MARCELLIN-CALMES
Primary tabs
A call for mindfulness-based interventions for cannabis-use disorders.
L'Encéphale
2023
;
S0013-7006(23)00118-5.
Substance use and CD4/CD8 ratio in HIV/HCV co-infected people receiving direct-acting antiviral treatment (ANRS CO13 HEPAVIH).
Journal of Viral Hepatitis
2023
;
30
:
897 - 900.
Patient-reported outcomes with direct-acting antiviral treatment for hepatitis C in West and Central Africa (TAC ANRS 12311 trial).
JHEP Reports Innovation in Hepatology
2023
;
5
(3)
:
100665.
Negative representations of night-shift work and mental health of public hospital healthcare workers in the COVID-19 era (Aladdin survey).
BMC Health Services Research
2023
;
23
(1)
:
187.
Integrating Human Immunodeficiency Virus-Specific Elements in the Treatment of Tobacco Dependence (ANRS 144 Inter-ACTIV).
Clinical Infectious Diseases
2022
;
75
(10)
:
1868-1871.
Stigma and care avoidance in people with unhealthy alcohol use: A call for research and action.
Journal of Hepatology
2022
;
77
(4)
:
1221 - 1222.
Author response: Improving patient‐provider communication by reducing stigma associated with liver disease.
Liver International
2022
;
42
(12)
:
2920 - 2920.
Hepatitis B in Senegal: A Successful Infant Vaccination Program but Urgent Need to Scale Up Screening and Treatment (ANRS 12356 AmBASS survey).
Hepatology Communications
2022
;
6
(5)
:
1005-1015.
https://aasldpubs.onlinelibrary.wiley.com/doi/10.1002/hep4.1879
Impact of the COVID-19 crisis on healthcare workers: The need to address quality of working life issues.
Respirology
2022
;
27
(6)
:
469 - 471.
Tobacco use in people living with HIV: The need for complementary descriptive data to see beyond the smoke screen.
International Journal of Drug Policy
2022
;
102
:
103616.
Sleep quality deterioration in healthcare workers during the COVID-19 pandemic: the role of work-related factors and mental health.
European Review for Medical and Pharmacological Sciences
2022
;
26
(8)
:
2648-2650.
Examining the Relationships between Mindfulness and Tobacco Craving Factors.
Substance Use and Misuse
2022
;
57
(4)
:
656-659.
HCV cure: an appropriate moment to reduce cannabis use in people living with HIV? (ANRS CO13 HEPAVIH data).
AIDS Research and Therapy
2022
;
19
(1)
Knowledge of liver fibrosis stage among adults with NAFLD/NASH improves adherence to lifestyle changes.
Liver International
2022
;
42
(5)
:
984 - 994.
Elevated coffee consumption is associated with a lower risk of elevated liver fibrosis biomarkers in patients treated for chronic hepatitis B (ANRS CO22 Hepather cohort).
Clinical Nutrition
2022
;
41
(3)
:
610-619.
Cannabis Use Is Inversely Associated with Metabolic Disorders in Hepatitis C-Infected Patients (ANRS CO22 Hepather Cohort).
Journal of Clinical Medicine
2022
;
11
(20)
:
6135.
Severe liver fibrosis in the HCV cure era: Major effects of social vulnerability, diabetes, and unhealthy behaviors.
JHEP Reports Innovation in Hepatology
2022
;
4
(6)
:
100481.
Mindfulness as a Protective Factor Against Increased Tobacco and Alcohol Use in Hospital Workers Following the First COVID-19-Related Lockdown: a Study in Southern France.
International Journal of Mental Health and Addiction
2022
;
23
:
1-21.
Sibling status, home birth, tattoos and stitches are risk factors for chronic hepatitis B virus infection in Senegalese children: A cross‐sectional survey.
Journal of Viral Hepatitis
2021
;
28
(11)
:
1515-1525.
https://onlinelibrary.wiley.com/doi/abs/10.1111/jvh.13589
Late presentation for HCV care: Time to target people with diabetes and/or hazardous alcohol use (ANRS CO22 HEPATHER cohort).
Liver International
2021
;
Online ahead of print.
Post‐HCV cure self‐reported changes in physical activity, eating behaviours, and fatigue in people living with HIV (ANRS CO13 HEPAVIH).
Journal of Viral Hepatitis
2021
;
28
(11)
:
1665 - 1667.
HCV Cure and Cannabis Abstinence Facilitate Tobacco Smoking Quit Attempts in HIV-HCV Co-Infected Patients (ANRS CO13 HEPAVIH Cohort Study).
AIDS and Behavior
2021
;
25
:
4141–4153.
Cannabis use and reduced risk of elevated fatty liver index in HIV-HCV co-infected patients: a longitudinal analysis (ANRS CO13 HEPAVIH).
Expert Review of Anti-infective Therapy
2021
;
19
(9)
:
1147-1156.
Alcohol Use Disorder and Hepatitis C Prevention and Care in People Who Inject Drugs: The State of Play.
Seminars in Liver Disease
2021
;
41
(2)
:
109-116.
Life after hepatitis C cure in HIV‐infected people who inject drugs and men who have sex with men treated with direct‐acting antivirals in France: Health perceptions and experiences from qualitative and quantitative findings (ANRS CO13 HEPAVIH).
Journal of Viral Hepatitis
2020
;
27
(12)
:
1462-1472.
Coffee Intake and Neurocognitive Performance in HIV/HCV Coinfected Patients (ANRS CO13 HEPAVIH).
Nutrients
2020
;
12
(9)
:
2532.
Alcohol Use Patterns and Liver Outcomes: Is There Really a Difference Between Drinking Beer and Drinking Wine?
Clinical Gastroenterology and Hepatology
2020
;
18
(7)
:
1650-1651.
HCV-Related Mortality Among HIV/HCV Co-infected Patients: The Importance of Behaviors in the HCV Cure Era (ANRS CO13 HEPAVIH Cohort).
AIDS and Behavior
2020
;
24
(4)
:
1069-1084.
Patient-reported symptoms during direct-acting antiviral treatment: A real-life study in HIV-HCV coinfected patients (ANRS CO13 HEPAVIH).
Journal of Hepatology
2020
;
72
(3)
:
588-591.
Cannabis Use and Plasma Human Immunodeficiency Virus (HIV) RNA Levels in Patients Coinfected With HIV and Hepatitis C Virus Receiving Antiretroviral Therapy: Data From the ANRS CO13 HEPAVIH Cohort.
Clinical Infectious Diseases
2020
;
ciaa117
:
Online ahead of print.
Cannabis use is associated with a lower risk of diabetes in chronic hepatitis C-infected patients (ANRS CO22 Hepather cohort).
Journal of Viral Hepatitis
2020
;
27
(12)
:
1473-1483.
Benefits of cannabis use for metabolic disorders and survival in people living with HIV with or without hepatitis C co-infection.
AIDS. Official journal of the international AIDS Society
2020
;
34
(6)
:
953-954.
Untreated alcohol use disorder in people who inject drugs (PWID) in France: a major barrier to HCV treatment uptake (the ANRS-FANTASIO study).
Addiction
2019
;
115
(3)
:
573-582.
France removes hepatitis C treatment prescriber restrictions—But what is the impact of the delay for key populations?
Liver International
2019
;
39
(12)
:
2418-2419.
Prevention and care of hepatitis B in the rural region of Fatick in Senegal : a healthcare workers’ perspective using a mixed methods approach.
BMC Health Services Research
2019
;
19
(1)
Sleep disturbances in HIV-HCV coinfected patients: indications for clinical management in the HCV cure era (ANRS CO13 HEPAVIH cohort).
European Journal of Gastroenterology & Hepatology
2019
;
Epub ahead of print.
Lower HCV treatment uptake in women who have received opioid agonist therapy before and during the DAA era: The ANRS FANTASIO project.
International Journal of Drug Policy
2019
;
72
:
61-68.
No influence of cannabis use on liver stiffness in HIV-HCV co-infected patients (ANRS CO13 HEPAVIH cohort study).
European Journal of Gastroenterology & Hepatology
2019
;
31
(2)
:
274-276.
Letter to the Editor: Patient-Reported Outcomes for Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis: Rationale for Expanded Use.
Hepatology
2019
;
70
(1)
:
443-444.
Wine Consumption and Lower Risk of Advanced Liver Fibrosis: A True Effect or Unmeasured Confounding? A Longitudinal Analysis (ANRS CO13 HEPAVIH Cohort).
The American Journal of Gastroenterology
2018
;
113
(11)
:
1729-1732.
Barriers and levers in screening and care for alcohol use disorders among French general practitioners: results from a computer-assisted telephone interview-based survey.
Alcoholism Treatment Quarterly
2018
;
37
(2)
:
207-224.
Posttraumatic Stress Disorder as a Significant Correlate of Voluntary Antiretroviral Treatment Interruption in Adult HIV-Infected Patients Followed up in French Hospitals.
Journal of Clinical Psychiatry
2018
;
79
(3)
Reply to: “Coffee consumption and decreased all-cause mortality – What is the true estimate of effect?”.
Journal of Hepatology
2018
;
68
(5)
:
1106.
Gender, Alcohol Use, and Fibrosis in Human Immunodeficiency Virus/Hepatitis C Virus–Coinfected Individuals.
Clinical Infectious Diseases
2018
;
66
(6)
:
983 - 984.
Impaired patient-reported outcomes persist in HIV-HCV co-infected patients and in cirrhotic patients despite HCV clearance.
Journal of Viral Hepatitis
2018
;
25
:
314 - 315.
Cannabinoids and reduced risk of hepatic steatosis in HIV-HCV co-infection: paving the way for future clinical research.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY
2018
;
16
(5)
:
377-380.
Unstable Housing Still a Barrier to Receiving HCV Treatment in France (ANRS CO13 HEPAVIH Cohort).
Digestive Diseases and Sciences
2017
;
62
(10)
:
2943 - 2944.
Significant reductions in alcohol use after hepatitis C treatment: results from the ANRS CO13-HEPAVIH cohort.
Addiction
2017
;
112
(9)
:
1669-1679.
No significant effect of cannabis use on the count and percentage of circulating CD4 T-cells in HIV-HCV co-infected patients (ANRS CO13-HEPAVIH French cohort).
Drug and Alcohol Review
2017
;
36
(2)
:
227-238.
The impact of coffee consumption on fibrosis and steatosis in HIV-HCV co-infected patients.
Journal of Hepatology
2017
;
68
:
840–866.
Sexual risk behaviour among people living with HIV according to the biomedical risk of transmission: results from the ANRS-VESPA2 survey.
Journal of the International AIDS Society
2016
;
19
(1)
:
20095.
Correlates of cocaine use during methadone treatment: implications for screening and clinical management (ANRS Methaville study).
Harm Reduction Journal
2015
;
13
(1)
:
12.
Suicidal risk among patients enrolled in methadone maintenance treatment: HCV status and implications for suicide prevention (ANRS Methaville).
Comprehensive Psychiatry
2015
;
62
:
123-131.
Methadone Induction in Primary Care for Opioid Dependence: A Pragmatic Randomized Trial (ANRS Methaville).
PLoS ONE
2014
;
9
(11)
:
112328 - 112328.
Predictors of non-prescribed opioid use after one year of methadone treatment: An attributable-risk approach (ANRS-Methaville trial).
Drug and Alcohol Dependence
2014
;
135
:
1-8.
Factors associated with HCV risk practices in methadone-maintained patients: the importance of considering the couple in prevention interventions.
Substance Abuse Treatment, Prevention, and Policy
2014
;
9
:
37.
Desire for a child among HIV-infected women receiving antiretroviral therapy in Cameroon: results from the national survey EVAL (ANRS 12-116).
AIDS Care
2010
;
22
(04)
:
441-451.
Psychosocial correlates of inconsistent condom use among HIVinfected patients enrolled in a structured ART interruptions trial in Coˆ te d’Ivoire: results from the TRIVACAN trial (ANRS 1269).
Tropical Medicine and International Health
2010
.
Impaired Anger Control as an Underappreciated Side Effect of Treatments for Chronic HCV Infection in HIV-HCV Coinfected Patients.
Journal of Clinical Gastroenterology
2008
;
42
:
92 - 96.
Do migrants overreport adherence to highly active antiretroviral therapy?: results from the French VESPA (ANRS-EN12) National Survey.
Journal of Acquired Immune Deficiency Syndromes - JAIDS
2006
;
42
(5)
:
646-7.